EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4
|
phenotype |
|
Finding
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Facial erythema
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Finding
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Primary cutaneous marginal zone B-cell lymphoma
|
disease |
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Primary Cutaneous Follicle Center Lymphoma
|
disease |
|
Neoplastic Process
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
T-lymphocyte deficiency
|
disease |
|
Disease or Syndrome
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Epidermodysplasia Verruciformis
|
disease |
Infections; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
64
|
9
|
0.320 |
moderate |
1.000 |
3 |
|
2012 |
2013 |
Viral Load result
|
phenotype |
|
Finding
|
65
|
91
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Pathological accumulation of air in tissues
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
69
|
6
|
0.100 |
None |
|
0 |
|
|
|
Combined immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
86
|
11
|
0.300 |
moderate |
1.000 |
1 |
|
2013 |
2013 |
Stomatitis
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
109
|
22
|
0.100 |
None |
|
0 |
|
|
|
Marginal Zone B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
124
|
25
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hairy Cell Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
143
|
4
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2011 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
149
|
527
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Lymphopenia
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
239
|
16
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Exanthema
|
phenotype |
Skin and Connective Tissue Diseases
|
Sign or Symptom
|
251
|
14
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Adult Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
399
|
27
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Childhood Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
399
|
29
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Human papilloma virus infection
|
disease |
Infections
|
Disease or Syndrome
|
429
|
42
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2012 |
Lymphoma, Follicular
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
477
|
83
|
0.030 |
None |
1.000 |
3 |
|
2006 |
2009 |
Burkitt Lymphoma
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
556
|
13
|
0.100 |
None |
|
0 |
|
|
|
Lymphoma, Non-Hodgkin
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
733
|
197
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
900
|
148
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |